AU2003268353A8 - Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection - Google Patents
Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infectionInfo
- Publication number
- AU2003268353A8 AU2003268353A8 AU2003268353A AU2003268353A AU2003268353A8 AU 2003268353 A8 AU2003268353 A8 AU 2003268353A8 AU 2003268353 A AU2003268353 A AU 2003268353A AU 2003268353 A AU2003268353 A AU 2003268353A AU 2003268353 A8 AU2003268353 A8 AU 2003268353A8
- Authority
- AU
- Australia
- Prior art keywords
- diagnosis
- prevention
- treatment
- streptococcus pneumoniae
- active infection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40708202P | 2002-08-30 | 2002-08-30 | |
| US60/407,082 | 2002-08-30 | ||
| PCT/US2003/027401 WO2004020609A2 (en) | 2002-08-30 | 2003-09-02 | Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2003268353A1 AU2003268353A1 (en) | 2004-03-19 |
| AU2003268353A8 true AU2003268353A8 (en) | 2004-03-19 |
Family
ID=31978415
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003268353A Abandoned AU2003268353A1 (en) | 2002-08-30 | 2003-09-02 | Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2003268353A1 (en) |
| WO (1) | WO2004020609A2 (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0407384A (en) | 2003-02-14 | 2006-02-21 | Pfizer Prod Inc | pyridines-triazoles as anti-inflammatory compounds |
| WO2006048757A2 (en) * | 2004-11-05 | 2006-05-11 | Pharmacia & Upjohn Company Llc | Anti-bacterial vaccine compositions |
| WO2006048753A2 (en) * | 2004-11-05 | 2006-05-11 | Pharmacia & Upjohn Company Llc | Anti-bacterial vaccine compositions |
| WO2008039838A2 (en) | 2006-09-27 | 2008-04-03 | St. Jude Children's Research Hospital | Synthetic streptococcus pneumoniae vaccine |
| GB0714963D0 (en) * | 2007-08-01 | 2007-09-12 | Novartis Ag | Compositions comprising antigens |
| BRPI0907010A2 (en) | 2008-02-01 | 2015-07-07 | Sanofi Pasteur Ltd | Analysis for the diagnosis of streptococcus pneumoniae |
| NZ597858A (en) | 2009-06-29 | 2014-01-31 | Genocea Biosciences Inc | Vaccines and compositions against streptococcus pneumoniae |
| CN103501808A (en) | 2010-12-03 | 2014-01-08 | 赛诺菲巴斯德有限公司 | Composition for immunization against streptococcus pneumoniae |
| CN103501809B (en) | 2011-01-20 | 2018-08-10 | 健诺西生物科学公司 | Vaccines and compositions against Streptococcus pneumoniae |
| CN104321335A (en) * | 2012-02-24 | 2015-01-28 | 诺华股份有限公司 | Pilus proteins and compositions |
| JP2019503201A (en) * | 2015-11-25 | 2019-02-07 | ウェイク フォーレスト ユニバーシティ ヘルス サイエンシーズWake Forest University Health Sciences | Pneumococcal inhibitor composition and method of use thereof |
| US11013793B2 (en) * | 2018-09-12 | 2021-05-25 | Affinivax, Inc. | Multivalent pneumococcal vaccines |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4469026B2 (en) * | 1996-10-31 | 2010-05-26 | ヒューマン ジノーム サイエンシーズ,インコーポレイテッド | Streptococcus pneumoniae antigens and vaccines |
-
2003
- 2003-09-02 AU AU2003268353A patent/AU2003268353A1/en not_active Abandoned
- 2003-09-02 WO PCT/US2003/027401 patent/WO2004020609A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003268353A1 (en) | 2004-03-19 |
| WO2004020609A2 (en) | 2004-03-11 |
| WO2004020609A3 (en) | 2004-07-15 |
| WO2004020609A9 (en) | 2004-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002255248A1 (en) | Diagnosis, treatment and research of mental disorders | |
| HUP0400477A3 (en) | Compounds and methods for treatment and diagnosis of chlamydial infection | |
| ZA200108215B (en) | Compositions and methods for treatment of staphylococcal infection. | |
| IL152553A0 (en) | Compounds and methods for the treatment and prevention of bacterial infection | |
| AUPR839001A0 (en) | Dosage form, device and methods of treatment | |
| AU2003268353A8 (en) | Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection | |
| WO2000058475A3 (en) | Streptococcus pneumoniae antigens | |
| EP1351699A4 (en) | Methods for improved diagnosis and treatment of mycobacterial infections | |
| MXPA03006776A (en) | Use of il-18 inhibitors for the treatment and/or prevention of heart disease. | |
| AU2002246545A1 (en) | Prevention and treatment of hcv infection employing antibodies directed against conformational epitopes | |
| AU2001259507A1 (en) | Compounds and methods for the diagnosis and treatment of ehrlichia infection | |
| PL371524A1 (en) | Combination therapy for the treatment of bacterial infections | |
| AU2003210266A1 (en) | Treatment, diagnosis and imaging of disease | |
| AU2003247841A1 (en) | Prevention and treatment of hcv infection employing antibodies directed against conformational and linear epitopes | |
| AU4204700A (en) | Compounds and methods for the diagnosis and treatment of (b. microti) infection | |
| AU4654500A (en) | Prevention, diagnosis and treatment of lyme disease | |
| AU2003282878A8 (en) | Diagnosis of invasive mold infection | |
| AU2002330724A1 (en) | Diagnosis, prevention and treatment of cancer | |
| AU2002249891A1 (en) | Compounds and methods for the diagnosis and treatment of babesia infection | |
| AU2002365941A1 (en) | Methods of diagnosis, monitoring and treatment of fertility | |
| EP1250145A4 (en) | C-ski oncogene-derived peptides for prevention, treatment, and diagnosis of cancer | |
| ZA200108013B (en) | Monthly closes for treatment of Streptococcus pneumoniae infections. | |
| WO2002024223A3 (en) | Prevention and treatment of streptococcal and staphylococcal infection | |
| AU2003255111A1 (en) | The use of n-acetyl-d-glucosamine for preparing medicines for urogenital tract infection's treatment and prevention | |
| WO2003096877A3 (en) | Prevention and treatment of streptococcal and staphylococcal infection |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |